U10 CA098413/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2000	1
2006	1
2007	1
2008	17
2009	30
2010	43
2011	50
2012	70
2013	68
2014	65
2015	61
2016	49
2017	55
2018	47
2019	46
2020	36
2021	40
2022	32
2023	52
2024	29
2025	9

1

Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes.

Chen W, Chang TC, Rabin KR, Raetz EA, Devidas M, Hunger SP, Ramirez NC, Mullighan CG, Loh ML, Wu G. Chen W, et al. JCO Clin Cancer Inform. 2025 May;9:e2400223. doi: 10.1200/CCI-24-00223. Epub 2025 May 2. JCO Clin Cancer Inform. 2025. PMID: 40315406 Free PMC article.

2

DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study.

Wang X, Singh P, Cejas RB, Zhou L, Sharafeldin N, Trainor PJ, Landier W, Cheng C, Hageman L, Wang F, Sapkota Y, Yasui Y, Hudson MM, Chow EJ, Armenian SH, Neglia JP, Hawkins DS, Ginsberg JP, Burridge PW, Armstrong GT, Bhatia S. Wang X, et al. Circ Genom Precis Med. 2025 Apr;18(2):e004813. doi: 10.1161/CIRCGEN.124.004813. Epub 2025 Mar 28. Circ Genom Precis Med. 2025. PMID: 40151933

3

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Aye JM, Xue W, Gao Z, Ladra M, Indelicato DJ, Sheyn A, Dasgupta R, Arnold MA, Shenoy A, Linardic CM, Venkatramani R. Aye JM, et al. Pediatr Blood Cancer. 2025 Jun;72(6):e31673. doi: 10.1002/pbc.31673. Epub 2025 Mar 19. Pediatr Blood Cancer. 2025. PMID: 40108481

4

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network.

Tie X, Shin M, Lee C, Perlman SB, Huemann Z, Weisman AJ, Castellino SM, Kelly KM, McCarten KM, Alazraki AL, Hu J, Cho SY, Bradshaw TJ. Tie X, et al. Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. Radiol Artif Intell. 2025. PMID: 39969278

5

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies.

Armstrong AE, Daw NC, Renfro LA, Geller JI, Kalapurakal JA, Khanna G, Paulino AC, Perlman EJ, Ehrlich PF, Gow KW, Warwick AB, Grundy PE, Fernandez CV, Mullen EA, Dome JS; Children's Oncology Group AREN0321 and AREN03B2 Study Committees. Armstrong AE, et al. Cancer. 2025 Jan 15;131(2):e35713. doi: 10.1002/cncr.35713. Cancer. 2025. PMID: 39803937

6

Reply to: Accurate Determinants of Outcome in ALL.

Chang TC, Chen W, Qu C, Cheng Z, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML. Chang TC, et al. J Clin Oncol. 2025 Mar 10;43(8):1039-1041. doi: 10.1200/JCO-24-02335. Epub 2024 Dec 23. J Clin Oncol. 2025. PMID: 39715469 No abstract available.

7

Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia.

Lamba J, Marchi F, Landwehr M, Schade AK, Shastri V, Ghavami M, Sckaff F, Marrero R, Nguyen N, Mansinghka V, Cao X, Slayton W, Starostik P, Ribeiro R, Rubnitz J, Klco J, Gamis A, Triche T Jr, Ries R, Kolb EA, Aplenc R, Alonzo T, Pounds S, Meshinchi S, Cogle C, Elsayed A. Lamba J, et al. Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-5450972. doi: 10.21203/rs.3.rs-5450972/v1. Res Sq. 2024. PMID: 39711573 Free PMC article. Preprint.

8

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321.

Geller JI, Renfro LA, Grundy PE, Perlman EJ, Kalapurakal JA, Ehrlich PF, Biegel J, Huff V, Warwick AB, Paulino A, Mullen EA, Daw NC, Hoffer FA, Tochner Z, Gow K, Gratias E, Ward DA, Anderson JR, Fernandez CV, Dome JS. Geller JI, et al. Pediatr Blood Cancer. 2025 Mar;72(3):e31490. doi: 10.1002/pbc.31490. Epub 2024 Dec 19. Pediatr Blood Cancer. 2025. PMID: 39702900

9

Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity.

Maillard M, Nguyen JQ, Yang W, Hoshitsuki K, Relling MV, Caudle KE, Crews KR, Jeha S, Inaba H, Pui CH, Bhatia S, Karol SE, Antillon-Klussmann FG, Haidar CE, Bhojwani D, Yang JJ. Maillard M, et al. Clin Pharmacol Ther. 2025 Mar;117(3):724-731. doi: 10.1002/cpt.3501. Epub 2024 Dec 17. Clin Pharmacol Ther. 2025. PMID: 39688234

10

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.

Mullighan C, Wangondu R, Ashcraft E, Chang TC, Roberts K, Brady S, Fan Y, Evans W, Relling M, Crews K, Yang J, Yang W, Pounds S, Wu G, Devidas M, Maloney K, Mattano L Jr, Schore R, Angiolillo A, Larsen E, Salzer W, Burke M, Loh M, Jeha S, Pui CH, Inaba H, Cheng C. Mullighan C, et al. Res Sq [Preprint]. 2024 Nov 11:rs.3.rs-5292018. doi: 10.21203/rs.3.rs-5292018/v1. Res Sq. 2024. Update in: Leukemia. 2025 May 13. doi: 10.1038/s41375-025-02633-3. PMID: 39606455 Free PMC article. Updated. Preprint.

11

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

Kannan S, Li Y, Baran N, Yang X, Ghotbaldini S, Zhang Tatarata Q, Yoshimura S, Li Z, Hsiao Y, Balachander S, Andersen CL, Cidado J, Yu J, Jain N, Yang JJ, Konopleva M. Kannan S, et al. Blood Adv. 2025 Feb 11;9(3):473-487. doi: 10.1182/bloodadvances.2024013423. Blood Adv. 2025. PMID: 39561378 Free PMC article.

12

Whole Lung Irradiation in Rhabdomyosarcoma With Lung Metastases: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Luo LY, Xue W, Qumseya A, Vasquez JC, Venkatramani R, Wolden SL, Casey DL. Luo LY, et al. J Clin Oncol. 2024 Dec 20;42(36):4263-4270. doi: 10.1200/JCO.24.00928. Epub 2024 Sep 10. J Clin Oncol. 2024. PMID: 39255438

13

Fertility preservation in pediatric central nervous system tumors: A report from the Children's Oncology Group.

Felker J, Bjornard K, Close A, Chavez J, Chow EJ, Meacham LR, Burns K. Felker J, et al. Pediatr Blood Cancer. 2024 Nov;71(11):e31246. doi: 10.1002/pbc.31246. Epub 2024 Aug 10. Pediatr Blood Cancer. 2024. PMID: 39126374

14

Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.

Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML. Chang TC, et al. J Clin Oncol. 2024 Oct 10;42(29):3491-3503. doi: 10.1200/JCO.23.02238. Epub 2024 Aug 9. J Clin Oncol. 2024. PMID: 39121442 Free PMC article.

15

Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.

H Elsayed A, Cao X, Marrero RJ, Nguyen NHK, Wu H, Ni Y, Ribeiro RC, Tobias H, Valk PJ, Béliveau F, Richard-Carpentier G, Hébert J, Zwaan CM, Gamis A, Kolb EA, Aplenc R, Alonzo TA, Meshinchi S, Rubnitz J, Pounds S, Lamba JK. H Elsayed A, et al. NPJ Precis Oncol. 2024 Aug 1;8(1):168. doi: 10.1038/s41698-024-00643-5. NPJ Precis Oncol. 2024. PMID: 39090192 Free PMC article.

16

A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study.

Espinoza AF, Bagatell R, McHugh K, Naranjo AH, Van Ryn C, Rojas Y, Lyons K, Guillerman RP, Kirby C, Brock P, Volchenboum S, Simon T, States L, Miller A, Krug B, Sarnacki S, Irtan S, Brisse HJ, Valteau-Couanet D, von Schweinitz D, Kammer B, Granata C, Pio L, Park JR, Nuchtern JG. Espinoza AF, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31218. doi: 10.1002/pbc.31218. Epub 2024 Jul 28. Pediatr Blood Cancer. 2024. PMID: 39072986

17

Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL.

Pabari R, McCarten K, Flerlage J, Lai H, Mauz-Körholz C, Dieckmann K, Palese M, Kaste S, Castellino SM, Kelly KM, Stoevesandt D, Kurch L. Pabari R, et al. Blood Adv. 2024 Sep 24;8(18):4856-4865. doi: 10.1182/bloodadvances.2023012346. Blood Adv. 2024. PMID: 39058968 Free PMC article.

18

Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies.

Schloemer NJ, Xue W, Qumseya A, Luo LY, Hiniker SM, Lautz TB, Rhee DS, Arnold MA, Venkatramani R. Schloemer NJ, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31200. doi: 10.1002/pbc.31200. Epub 2024 Jul 17. Pediatr Blood Cancer. 2024. PMID: 39016936

19

Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.

Guest EM, Kairalla JA, Devidas M, Hibbitts E, Carroll AJ, Heerema NA, Kubaney HR, August MA, Ramesh S, Yoo B, Farooqi MS, Pauly MG, Wechsler DS, Miles RR, Reid JM, Kihei CD, Gore L, Raetz EA, Hunger SP, Loh ML, Brown PA. Guest EM, et al. Haematologica. 2024 Dec 1;109(12):3918-3927. doi: 10.3324/haematol.2024.285158. Haematologica. 2024. PMID: 38867582 Free PMC article. Clinical Trial.

20

Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.

Douglass DP, Coffin CM, Randall RL, Yang Y, Barkauskas DA, Million L, McCarville MB, Pappo AS, Weiss AR, Spunt SL. Douglass DP, et al. Pediatr Blood Cancer. 2024 Aug;71(8):e31062. doi: 10.1002/pbc.31062. Epub 2024 May 16. Pediatr Blood Cancer. 2024. PMID: 38757485

21

Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.

Kumar P, Willard VW, Embry L, Naranjo A, LaBarre B, Matthay KK, de Alarcon PA. Kumar P, et al. Pediatr Blood Cancer. 2024 Jul;71(7):e31039. doi: 10.1002/pbc.31039. Epub 2024 Apr 30. Pediatr Blood Cancer. 2024. PMID: 38689540

22

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.

Tie X, Shin M, Lee C, Perlman SB, Huemann Z, Weisman AJ, Castellino SM, Kelly KM, McCarten KM, Alazraki AL, Hu J, Cho SY, Bradshaw TJ. Tie X, et al. ArXiv [Preprint]. 2024 Oct 1:arXiv:2404.08611v2. ArXiv. 2024. Update in: Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. PMID: 38659641 Free PMC article. Updated. Preprint.

23

Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534.

Romao RLP, Aldrink JH, Renfro LA, Mullen EA, Murphy AJ, Brzezinski J, Malek MM, Benedetti DJ, Cost NG, Smith E, Dome JS, Davidoff AM, Treece A, Parsons LN, Fernandez CV, Tornwall B, Shamberger RC, Paulino A, Kalapurakal JA, Geller JI, Ehrlich PF. Romao RLP, et al. Pediatr Blood Cancer. 2024 Jul;71(7):e30981. doi: 10.1002/pbc.30981. Epub 2024 Apr 18. Pediatr Blood Cancer. 2024. PMID: 38637871

24

Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.

Spunt SL, Xue W, Gao Z, Hayes Dixon A, Million L, Polites SF, Vasudevan SA, Kao SC, McCarville MB, Parham DM, Barkauskas DA, Cai Z, Cost C, Mascarenhas L, Weiss AR. Spunt SL, et al. Cancer. 2024 Aug 1;130(15):2683-2693. doi: 10.1002/cncr.35305. Epub 2024 Apr 3. Cancer. 2024. PMID: 38567652

25

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Martin-Giacalone BA, Li H, Scheurer ME, Casey DL, Dugan-Perez S, Marquez-Do DA, Muzny D, Gibbs RA, Barkauskas DA, Hall D, Stewart DR, Schiffman JD, McEvoy MT, Khan J, Malkin D, Linardic CM, Crompton BD, Shern JF, Skapek SX, Venkatramani R, Hawkins DS, Sabo A, Plon SE, Lupo PJ. Martin-Giacalone BA, et al. JAMA Netw Open. 2024 Mar 4;7(3):e244170. doi: 10.1001/jamanetworkopen.2024.4170. JAMA Netw Open. 2024. PMID: 38546643 Free PMC article.

26

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Escherich CS, Chen W, Li Y, Yang W, Nishii R, Li Z, Raetz EA, Devidas M, Wu G, Nichols KE, Inaba H, Pui CH, Jeha S, Camitta BM, Larsen E, Hunger SP, Loh ML, Yang JJ. Escherich CS, et al. Blood. 2024 May 30;143(22):2270-2283. doi: 10.1182/blood.2023023336. Blood. 2024. PMID: 38446568 Free PMC article. Clinical Trial.

27

Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.

Benedetti DJ, Renfro LA, Tfirn I, Daw NC, Kalapurakal JA, Ehrlich PF, Khanna G, Perlman E, Warwick A, Gow KW, Paulino AC, Seibel NL, Grundy P, Fernandez CV, Geller JI, Mullen EA, Dome JS. Benedetti DJ, et al. Cancer. 2024 Jul 1;130(13):2361-2371. doi: 10.1002/cncr.35266. Epub 2024 Feb 23. Cancer. 2024. PMID: 38396300

28

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.

DelRocco NJ, Loh ML, Borowitz MJ, Gupta S, Rabin KR, Zweidler-McKay P, Maloney KW, Mattano LA, Larsen E, Angiolillo A, Schore RJ, Burke MJ, Salzer WL, Wood BL, Carroll AJ, Heerema NA, Reshmi SC, Gastier-Foster JM, Harvey R, Chen IM, Roberts KG, Mullighan CG, Willman C, Winick N, Carroll WL, Rau RE, Teachey DT, Hunger SP, Raetz EA, Devidas M, Kairalla JA. DelRocco NJ, et al. Leukemia. 2024 Apr;38(4):720-728. doi: 10.1038/s41375-024-02166-1. Epub 2024 Feb 15. Leukemia. 2024. PMID: 38360863 Free PMC article.

29

Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL.

Wolfson JA, Grimes AC, Nuno M, Kerber CL, Ramakrishnan S, Beauchemin M, Dickens D, Levine JM, Roth ME, Scialla M, Woods W, Vargas S, Boayue KB, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Wolfson JA, et al. JCO Oncol Pract. 2024 Apr;20(4):491-502. doi: 10.1200/OP.23.00328. Epub 2024 Jan 22. JCO Oncol Pract. 2024. PMID: 38252911 Free PMC article.

30

Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.

Lovvorn HN 3rd, Renfro LA, Benedetti DJ, Kotagal M, Phelps HM, Ehrlich PF, Lo AC, Sandberg JK, Treece AL, Gow KW, Glick RD, Davidoff AM, Cost NG, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Lovvorn HN 3rd, et al. J Am Coll Surg. 2024 Apr 1;238(4):733-749. doi: 10.1097/XCS.0000000000000999. Epub 2024 Mar 15. J Am Coll Surg. 2024. PMID: 38251681 Free PMC article.

31

Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS.

Sharafeldin N, Zhou L, Singh P, Crossman DK, Wang X, Hageman L, Landier W, Blanco JG, Burridge PW, Sapkota Y, Yasui Y, Armstrong GT, Robison LL, Hudson MM, Oeffinger K, Chow EJ, Armenian SH, Weisdorf DJ, Bhatia S. Sharafeldin N, et al. JACC CardioOncol. 2023 Sep 14;5(6):807-818. doi: 10.1016/j.jaccao.2023.06.007. eCollection 2023 Dec. JACC CardioOncol. 2023. PMID: 38205005 Free PMC article.

32

BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2.

Goldstein JA, Renfro LA, Jennings LJ, Mullen EA, Geller J, Vallance K, Fernandez CV, Perlman EJ. Goldstein JA, et al. Arch Pathol Lab Med. 2024 Oct 1;148(10):e362-e366. doi: 10.5858/arpa.2022-0528-OA. Arch Pathol Lab Med. 2024. PMID: 38116848 Free PMC article.

33

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.

Murphy AJ, Cheng C, Williams J, Shaw TI, Pinto EM, Dieseldorff-Jones K, Brzezinski J, Renfro LA, Tornwall B, Huff V, Hong AL, Mullen EA, Crompton B, Dome JS, Fernandez CV, Geller JI, Ehrlich PF, Mulder H, Oak N, Maciezsek J, Jablonowski CM, Fleming AM, Pichavaram P, Morton CL, Easton J, Nichols KE, Clay MR, Santiago T, Zhang J, Yang J, Zambetti GP, Wang Z, Davidoff AM, Chen X. Murphy AJ, et al. Nat Commun. 2023 Dec 18;14(1):8006. doi: 10.1038/s41467-023-43730-0. Nat Commun. 2023. PMID: 38110397 Free PMC article.

34

Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232.

Mattano LA Jr, Devidas M, Loh ML, Raetz EA, Chen Z, Winick NJ, Hunger SP, Carroll WL, Larsen EC. Mattano LA Jr, et al. Leukemia. 2024 Feb;38(2):258-265. doi: 10.1038/s41375-023-02099-1. Epub 2023 Dec 7. Leukemia. 2024. PMID: 38062123 Free PMC article. Clinical Trial.

35

Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.

Benedetti DJ, Varela CR, Renfro LA, Tornwall B, Dix DB, Ehrlich PF, Glick RD, Kalapurakal J, Perlman E, Gratias E, Seibel NL, Geller JI, Khanna G, Malogolowkin M, Grundy P, Fernandez CV, Dome JS, Mullen EA. Benedetti DJ, et al. Cancer. 2024 Mar 15;130(6):947-961. doi: 10.1002/cncr.35099. Epub 2023 Nov 7. Cancer. 2024. PMID: 37933882 Free PMC article. Clinical Trial.

36

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

Evageliou N, Renfro LA, Geller J, Perlman E, Kalapurakal J, Paulino A, Dix D, Eklund MJ, Murphy AJ, Romao RLP, Ehrlich PF, Varela CR, Vallance K, Fernandez CV, Dome JS, Mullen EA. Evageliou N, et al. Cancer. 2024 Mar 1;130(5):792-802. doi: 10.1002/cncr.35084. Epub 2023 Oct 30. Cancer. 2024. PMID: 37902955 Free PMC article.

37

Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.

Rabin KR, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler JK, Yang JJ, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Roberts KG, Mullighan CG, Harvey RC, Chen IM, Willman CL, Reshmi SC, Gastier-Foster JM, Bhojwani D, Rheingold SR, Maloney KW, Mattano LA, Larsen EC, Schore RJ, Burke MJ, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Loh ML, Hunger SP, Angiolillo AL. Rabin KR, et al. J Clin Oncol. 2024 Jan 10;42(2):218-227. doi: 10.1200/JCO.23.00389. Epub 2023 Oct 27. J Clin Oncol. 2024. PMID: 37890117 Free PMC article.

38

Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.

Schloemer NJ, Xue W, Qumseya A, Luo LY, Hiniker SM, Lautz TB, Rhee DS, Arnold MA, Venkatramani R. Schloemer NJ, et al. Pediatr Blood Cancer. 2023 Dec;70(12):e30701. doi: 10.1002/pbc.30701. Epub 2023 Oct 2. Pediatr Blood Cancer. 2023. PMID: 37783659 Free PMC article.

39

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.

Singh P, Shah DA, Jouni M, Cejas RB, Crossman DK, Magdy T, Qiu S, Wang X, Zhou L, Sharafeldin N, Hageman L, McKenna DE, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Bhatia R, Burridge PW, Bhatia S. Singh P, et al. J Am Heart Assoc. 2023 Oct 3;12(19):e029954. doi: 10.1161/JAHA.123.029954. Epub 2023 Sep 26. J Am Heart Assoc. 2023. PMID: 37750583 Free PMC article.

40

SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731.

Elgarten CW, Kairalla JA, Thompson JC, Miller TP, Wang C, Conway S, Loh ML, Raetz EA, Gupta S, Rau RE, Angiolillo A, Rabin KR, Alexander S. Elgarten CW, et al. EJHaem. 2023 May 10;4(3):745-750. doi: 10.1002/jha2.697. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601850 Free PMC article.

41

Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.

Rodwin RL, DelRocco NJ, Hibbitts E, Devidas M, Whitley MK, Mohrmann CE, Schore RJ, Raetz E, Winick NJ, Hunger SP, Loh ML, Hockenberry MJ, Ma X, Angiolillo AL, Ness KK, Kairalla JA, Kadan-Lottick NS. Rodwin RL, et al. Pediatr Blood Cancer. 2023 Nov;70(11):e30634. doi: 10.1002/pbc.30634. Epub 2023 Aug 17. Pediatr Blood Cancer. 2023. PMID: 37592363 Free PMC article.

42

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.

Wood BL, Devidas M, Summers RJ, Chen Z, Asselin B, Rabin KR, Zweidler-McKay PA, Winick NJ, Borowitz MJ, Carroll WL, Raetz EA, Loh ML, Hunger SP, Dunsmore KP, Teachey DT, Winter SS. Wood BL, et al. Blood. 2023 Dec 14;142(24):2069-2078. doi: 10.1182/blood.2023020678. Blood. 2023. PMID: 37556734 Free PMC article. Clinical Trial.

43

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.

Singh P, Zhou L, Shah DA, Cejas RB, Crossman DK, Jouni M, Magdy T, Wang X, Sharafeldin N, Hageman L, McKenna DE, Horvath S, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Burridge PW, Bhatia S. Singh P, et al. Sci Rep. 2023 Aug 4;13(1):12683. doi: 10.1038/s41598-023-39357-2. Sci Rep. 2023. PMID: 37542143 Free PMC article.

44

Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.

Leary SES, Onar-Thomas A, Fangusaro J, Gottardo NG, Cohen K, Smith A, Huang A, Haas-Kogan D, Fouladi M; COG Central Nervous System Committee. Leary SES, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30600. doi: 10.1002/pbc.30600. Epub 2023 Aug 3. Pediatr Blood Cancer. 2023. PMID: 37534382 Free PMC article.

45

Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.

Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM; COG Hodgkin Lymphoma Committee. Castellino SM, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30580. doi: 10.1002/pbc.30580. Epub 2023 Jul 28. Pediatr Blood Cancer. 2023. PMID: 37505794 Free PMC article.

46

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.

Escherich C, Chen W, Li Y, Yang W, Nishii R, Li Z, Raetz EA, Devidas M, Wu G, Nichols KE, Inaba H, Pui CH, Jeha S, Camitta BM, Larsen E, Hunger SP, Loh ML, Yang JJ. Escherich C, et al. Res Sq [Preprint]. 2023 Jul 21:rs.3.rs-3171814. doi: 10.21203/rs.3.rs-3171814/v1. Res Sq. 2023. Update in: Blood. 2024 May 30;143(22):2270-2283. doi: 10.1182/blood.2023023336. PMID: 37503171 Free PMC article. Updated. Preprint.

47

Children's Oncology Group's 2023 blueprint for research: Bone tumors.

Reed DR, Grohar P, Rubin E, Binitie O, Krailo M, Davis J, DuBois SG, Janeway KA. Reed DR, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30583. doi: 10.1002/pbc.30583. Epub 2023 Jul 27. Pediatr Blood Cancer. 2023. PMID: 37501549 Free PMC article.

48

Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.

Winestone LE, Beauchemin MP, Bona K, Kahn J, Prasad P, Robles JM, Velez MC; Diversity and Health Disparities Committee. Winestone LE, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30592. doi: 10.1002/pbc.30592. Epub 2023 Jul 28. Pediatr Blood Cancer. 2023. PMID: 37501542 Free PMC article.

49

Children's Oncology Group's 2023 blueprint for research: Liver tumors.

O'Neill AF, Meyers RL, Katzenstein HM, Geller JI, Tiao GM, López-Terrada D, Malogolowkin M; Liver Tumor Committee. O'Neill AF, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30576. doi: 10.1002/pbc.30576. Epub 2023 Jul 26. Pediatr Blood Cancer. 2023. PMID: 37495540 Free PMC article.

50

Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.

Raetz EA, Bhojwani D, Devidas M, Gore L, Rabin KR, Tasian SK, Teachey DT, Loh ML. Raetz EA, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30585. doi: 10.1002/pbc.30585. Epub 2023 Jul 25. Pediatr Blood Cancer. 2023. PMID: 37489549 Free PMC article.

51

Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.

Raetz EA, Rebora P, Conter V, Schrappe M, Devidas M, Escherich G, Imai C, De Moerloose B, Schmiegelow K, Burns MA, Elitzur S, Pieters R, Attarbaschi A, Yeoh A, Pui CH, Stary J, Cario G, Bodmer N, Moorman AV, Buldini B, Vora A, Valsecchi MG. Raetz EA, et al. J Clin Oncol. 2023 Nov 10;41(32):5025-5034. doi: 10.1200/JCO.23.00088. Epub 2023 Jul 24. J Clin Oncol. 2023. PMID: 37487146 Free PMC article.

52

Children's Oncology Group's 2023 blueprint for research: Radiation oncology.

Kalapurakal JA, Wolden SL, Haas-Kogan D, Laack NN, Hua CH, Paulino AC, Hill-Kayser CE, Hoppe BS, Fitzgerald TJ; COG Radiation Oncology Discipline Committee. Kalapurakal JA, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30593. doi: 10.1002/pbc.30593. Epub 2023 Jul 24. Pediatr Blood Cancer. 2023. PMID: 37486145 Free PMC article.

53

Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.

Cooper TM, Alonzo TA, Tasian SK, Kutny MA, Hitzler J, Pollard JA, Aplenc R, Meshinchi S, Kolb EA. Cooper TM, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30584. doi: 10.1002/pbc.30584. Epub 2023 Jul 21. Pediatr Blood Cancer. 2023. PMID: 37480164 Free PMC article.

54

Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation.

Kitko CL, Bollard CM, Cairo MS, Chewning J, Fry TJ, Pulsipher MA, Shenoy S, Wall DA, Levine JE. Kitko CL, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30577. doi: 10.1002/pbc.30577. Epub 2023 Jul 21. Pediatr Blood Cancer. 2023. PMID: 37480158 Free PMC article.

55

Children's Oncology Group's 2023 blueprint for research: Renal tumors.

Geller JI, Hong AL, Vallance KL, Evageliou N, Aldrink JH, Cost NG, Treece AL, Renfro LA, Mullen EA; COG Renal Tumor Committee. Geller JI, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30586. doi: 10.1002/pbc.30586. Epub 2023 Jul 21. Pediatr Blood Cancer. 2023. PMID: 37477907 Free PMC article.

56

Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.

Bhuta R, Shah R, Gell JJ, Poynter JN, Bagrodia A, Dicken BJ, Pashankar F, Frazier AL, Shaikh F. Bhuta R, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30562. doi: 10.1002/pbc.30562. Epub 2023 Jul 14. Pediatr Blood Cancer. 2023. PMID: 37449938 Free PMC article.

57

Children's Oncology Group's 2023 blueprint for research: Epidemiology.

Lupo PJ, Marcotte EL, Scheurer ME, Poynter JN, Spector LG; COG Epidemiology Committee. Lupo PJ, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30566. doi: 10.1002/pbc.30566. Epub 2023 Jul 14. Pediatr Blood Cancer. 2023. PMID: 37449937 Free PMC article.

58

Children's Oncology Group's 2023 blueprint for research: Young investigators.

Esbenshade AJ, Kahalley LS, Wistinghausen B, Cash T, Baertschiger RM, Zarnegar-Lumley S, Green A, Dhall G; COG Young Investigators Committee. Esbenshade AJ, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30567. doi: 10.1002/pbc.30567. Epub 2023 Jul 12. Pediatr Blood Cancer. 2023. PMID: 37438856 Free PMC article.

59

Children's Oncology Group's 2023 blueprint for research.

Hawkins DS, Gore L. Hawkins DS, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30569. doi: 10.1002/pbc.30569. Epub 2023 Jul 11. Pediatr Blood Cancer. 2023. PMID: 37433635 Free PMC article. No abstract available.

60

Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.

Fox E, Parsons DW, Weigel BJ; Developmental Therapeutics Committee. Fox E, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30563. doi: 10.1002/pbc.30563. Epub 2023 Jul 10. Pediatr Blood Cancer. 2023. PMID: 37430453 Free PMC article.

61

Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas.

Oberoi S, Crane JN, Haduong JH, Rudzinski ER, Wolden SL, Dasgupta R, Linardic CM, Weiss AR, Venkatramani R; the Children's Oncology Group Soft Tissue Sarcoma Committee. Oberoi S, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30556. doi: 10.1002/pbc.30556. Epub 2023 Jul 10. Pediatr Blood Cancer. 2023. PMID: 37430436 Free PMC article.

62

Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.

Esbenshade AJ, Sung L, Brackett J, Dupuis LL, Fisher BT, Grimes A, Miller TP, Ullrich NJ, Dvorak CC; Cancer Control and Supportive Care Committee. Esbenshade AJ, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30568. doi: 10.1002/pbc.30568. Epub 2023 Jul 10. Pediatr Blood Cancer. 2023. PMID: 37430431 Free PMC article.

63

Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.

Hoff FW, Qiu Y, Brown BD, Gerbing RB, Leonti AR, Ries RE, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, Horton TM, Kornblau SM. Hoff FW, et al. Proteomics Clin Appl. 2023 Nov;17(6):e2200109. doi: 10.1002/prca.202200109. Epub 2023 Jun 7. Proteomics Clin Appl. 2023. PMID: 37287368 Free PMC article.

64

Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.

Faulk KE, Kairalla JA, Dreyer ZE, Carroll AJ, Heerema NA, Devidas M, Carroll WL, Raetz EA, Loh ML, Hunger SP, Borowitz M, Wang C, Guest E, Brown PA. Faulk KE, et al. Pediatr Blood Cancer. 2023 May 31:e30467. doi: 10.1002/pbc.30467. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37259259 Free PMC article.

65

TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.

Fair D, Maese L, Chi YY, Li M, Hawkins DS, Venkatramani R, Rudzinski E, Parham D, Teot L, Malkin D, Plon SE, Li H, Sabo A, Lupo PJ, Schiffman JD. Fair D, et al. Pediatr Blood Cancer. 2023 May 17:e30413. doi: 10.1002/pbc.30413. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37194615 Free PMC article.

66

Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.

Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers D. Warren KE, et al. J Clin Oncol. 2023 Jun 20;41(18):3374-3383. doi: 10.1200/JCO.22.01777. Epub 2023 May 1. J Clin Oncol. 2023. PMID: 37126770 Free PMC article. Clinical Trial.

67

Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.

Bender HG, Irwin MS, Hogarty MD, Castleberry R, Maris JM, Kao PC, Zhang FF, Naranjo A, Cohn SL, London WB. Bender HG, et al. J Clin Oncol. 2023 Jun 10;41(17):3149-3159. doi: 10.1200/JCO.22.01946. Epub 2023 Apr 25. J Clin Oncol. 2023. PMID: 37098238 Free PMC article.

68

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group.

Munnikhuysen SR, Ekpo PA, Xue W, Gao Z, Lupo PJ, Venkatramani R, Heske CM. Munnikhuysen SR, et al. Cancer Med. 2023 Jun;12(11):12777-12791. doi: 10.1002/cam4.5921. Epub 2023 Apr 20. Cancer Med. 2023. PMID: 37081771 Free PMC article.

69

Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.

Li Z, Chang TC, Junco JJ, Devidas M, Li Y, Yang W, Huang X, Hedges DJ, Cheng Z, Shago M, Carroll AJ, Heerema NA, Gastier-Foster J, Wood BL, Borowitz MJ, Sanclemente L, Raetz EA, Hunger SP, Feingold E, Rosser TC, Sherman SL, Loh ML, Mullighan CG, Yu J, Wu G, Lupo PJ, Rabin KR, Yang JJ. Li Z, et al. Blood. 2023 Jul 13;142(2):172-184. doi: 10.1182/blood.2023019765. Blood. 2023. PMID: 37001051 Free PMC article.

70

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group.

Hoff FW, Griffen TL, Brown BD, Horton TM, Burger J, Wierda W, Hubner SE, Qiu Y, Kornblau SM. Hoff FW, et al. Int J Mol Sci. 2023 Mar 13;24(6):5460. doi: 10.3390/ijms24065460. Int J Mol Sci. 2023. PMID: 36982537 Free PMC article.

71

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932.

Schore RJ, Angiolillo AL, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Kadan-Lottick NS, Maloney K, Wang C, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Schore RJ, et al. Leukemia. 2023 Jun;37(6):1375-1378. doi: 10.1038/s41375-023-01870-8. Epub 2023 Mar 25. Leukemia. 2023. PMID: 36966262 Free PMC article. No abstract available.

72

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.

Milgrom SA, Kim J, Pei Q, Lee I, Hoppe BS, Wu Y, Hodgson D, Kessel S, McCarten KM, Roberts K, Lo AC, Cole PD, Kelly KM, Cho SY. Milgrom SA, et al. Br J Haematol. 2023 Jun;201(6):1192-1199. doi: 10.1111/bjh.18734. Epub 2023 Mar 15. Br J Haematol. 2023. PMID: 36922022 Free PMC article.

73

KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.

Robinson BW, Kairalla JA, Devidas M, Carroll AJ, Harvey RC, Heerema NA, Willman CL, Ball AR, Woods EC, Ballantyne NC, Urtishak KA, Behm FG, Reaman GH, Hilden JM, Camitta BM, Winick NJ, Pullen J, Carroll WL, Hunger SP, Dreyer ZE, Felix CA. Robinson BW, et al. Haematologica. 2023 Oct 1;108(10):2865-2871. doi: 10.3324/haematol.2022.281552. Haematologica. 2023. PMID: 36861410 Free PMC article. No abstract available.

74

Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.

Chisholm KM, Smith J, Heerema-McKenney AE, Choi JK, Ries RE, Hirsch BA, Raimondi SC, Wang YC, Dang A, Alonzo TA, Sung L, Aplenc R, Gamis AS, Meshinchi S, Kahwash SB. Chisholm KM, et al. Pediatr Blood Cancer. 2023 May;70(5):e30251. doi: 10.1002/pbc.30251. Epub 2023 Feb 15. Pediatr Blood Cancer. 2023. PMID: 36789545 Free PMC article.

75

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.

Gupta S, Dai Y, Chen Z, Winestone LE, Teachey DT, Bona K, Aplenc R, Rabin KR, Zweidler-McKay P, Carroll AJ, Heerema NA, Gastier-Foster J, Borowitz MJ, Wood BL, Maloney KW, Mattano LA Jr, Larsen EC, Angiolillo AL, Burke MJ, Salzer WL, Winter SS, Brown PA, Guest EM, Dunsmore KP, Kairalla JA, Winick NJ, Carroll WL, Raetz EA, Hunger SP, Loh ML, Devidas M. Gupta S, et al. Lancet Haematol. 2023 Feb;10(2):e129-e141. doi: 10.1016/S2352-3026(22)00371-4. Lancet Haematol. 2023. PMID: 36725118 Free PMC article.

76

Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Abbou S, Klega K, Tsuji J, Tanhaemami M, Hall D, Barkauskas DA, Krailo MD, Cibulskis C, Nag A, Thorner AR, Pollock S, Imamovic-Tuco A, Shern JF, DuBois SG, Venkatramani R, Hawkins DS, Crompton BD. Abbou S, et al. J Clin Oncol. 2023 May 1;41(13):2382-2393. doi: 10.1200/JCO.22.00409. Epub 2023 Feb 1. J Clin Oncol. 2023. PMID: 36724417 Free PMC article.

77

Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.

Chow EJ, Aggarwal S, Doody DR, Aplenc R, Armenian SH, Baker KS, Bhatia S, Blythe N, Colan SD, Constine LS, Freyer DR, Kopp LM, Laverdière C, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Lipshultz SE. Chow EJ, et al. J Clin Oncol. 2023 Apr 20;41(12):2248-2257. doi: 10.1200/JCO.22.02423. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669148 Free PMC article.

78

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.

Gossai NP, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, Rabin KR, Loh ML, Raetz EA, Winick NJ, Burke MJ, Carroll AJ, Esiashvili N, Heerema NA, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DT. Gossai NP, et al. Blood. 2023 Apr 13;141(15):1802-1811. doi: 10.1182/blood.2022018653. Blood. 2023. PMID: 36603187 Free PMC article. Clinical Trial.

79

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.

Escherich C, Chen W, Miyamoto S, Namikawa Y, Yang W, Teachey DT, Li Z, Raetz EA, Larsen E, Devidas M, Martin PL, Bowman WP, Wu G, Pui CH, Hunger SP, Loh ML, Takagi M, Yang JJ. Escherich C, et al. Blood Adv. 2023 May 23;7(10):2177-2180. doi: 10.1182/bloodadvances.2022008563. Blood Adv. 2023. PMID: 36576946 Free PMC article. No abstract available.

80

Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.

Alvarez E, He J, Spunt SL, Hayes-Jordan A, Kao SC, Parham DM, Million L, Weiss AR, Barkauskas DA. Alvarez E, et al. Eur J Cancer. 2023 Feb;180:89-98. doi: 10.1016/j.ejca.2022.11.014. Epub 2022 Nov 25. Eur J Cancer. 2023. PMID: 36566574 Free PMC article.

81

Genome-Wide Association Study Identifies ROBO2 as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors.

Wang X, Singh P, Zhou L, Sharafeldin N, Landier W, Hageman L, Burridge P, Yasui Y, Sapkota Y, Blanco JG, Oeffinger KC, Hudson MM, Chow EJ, Armenian SH, Neglia JP, Ritchey AK, Hawkins DS, Ginsberg JP, Robison LL, Armstrong GT, Bhatia S. Wang X, et al. J Clin Oncol. 2023 Mar 20;41(9):1758-1769. doi: 10.1200/JCO.22.01527. Epub 2022 Dec 12. J Clin Oncol. 2023. PMID: 36508697 Free PMC article.

82

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

Castellino SM, Pei Q, Parsons SK, Hodgson D, McCarten K, Horton T, Cho S, Wu Y, Punnett A, Dave H, Henderson TO, Hoppe BS, Charpentier AM, Keller FG, Kelly KM. Castellino SM, et al. N Engl J Med. 2022 Nov 3;387(18):1649-1660. doi: 10.1056/NEJMoa2206660. N Engl J Med. 2022. PMID: 36322844 Free PMC article. Clinical Trial.

83

Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study.

Attarbaschi A, Möricke A, Harrison CJ, Mann G, Baruchel A, De Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow K, Silverman LB, Stary J, Vora A, Pui CH, Schrappe M, Zimmermann M; Ponte-di-Legno Childhood Acute Lymphoblastic Leukemia Working Group. Attarbaschi A, et al. J Clin Oncol. 2023 Mar 1;41(7):1404-1422. doi: 10.1200/JCO.22.01297. Epub 2022 Oct 18. J Clin Oncol. 2023. PMID: 36256911 Free PMC article.

84

Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.

Shulman DS, Chen S, Hall D, Nag A, Thorner AR, Lessnick SL, Stegmaier K, Janeway KA, DuBois SG, Krailo MD, Barkauskas DA, Church AJ, Crompton BD. Shulman DS, et al. Br J Cancer. 2022 Dec;127(12):2220-2226. doi: 10.1038/s41416-022-01977-2. Epub 2022 Oct 11. Br J Cancer. 2022. PMID: 36221002 Free PMC article.

85

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma.

Lalchungnunga H, Hao W, Maris JM, Asgharzadeh S, Henrich KO, Westermann F, Tweddle DA, Schwalbe EC, Strathdee G. Lalchungnunga H, et al. Br J Cancer. 2022 Nov;127(11):2006-2015. doi: 10.1038/s41416-022-01988-z. Epub 2022 Sep 29. Br J Cancer. 2022. PMID: 36175618 Free PMC article.

86

Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O'Brien MM, Rabin KR, Rau RE, Rheingold SR, Wang C, Wood C, Raetz EA, Loh ML, Alexander S, Miller TP. Elgarten CW, et al. Pediatr Blood Cancer. 2022 Nov;69(11):e29937. doi: 10.1002/pbc.29937. Epub 2022 Sep 9. Pediatr Blood Cancer. 2022. PMID: 36083863 Free PMC article.

87

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).

Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. Dunkel IJ, et al. J Clin Oncol. 2022 Nov 20;40(33):3839-3847. doi: 10.1200/JCO.21.02337. Epub 2022 Jul 12. J Clin Oncol. 2022. PMID: 35820112 Free PMC article. Clinical Trial.

88

Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731.

Vasudevan SA, Meyers RL, Finegold MJ, López-Terrada D, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, Malogolowkin MH, Krailo MD, Piao J, Randazzo J, Towbin AJ, BethMcCarville M, O'Neill AF, Furman WL, Rodriguez-Galindo C, Katzenstein HM. Vasudevan SA, et al. J Pediatr Surg. 2022 Oct;57(10):251-256. doi: 10.1016/j.jpedsurg.2022.05.022. Epub 2022 Jun 9. J Pediatr Surg. 2022. PMID: 35810020 Free PMC article.

89

A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials.

Gbadamosi MO, Shastri VM, Elsayed AH, Ries R, Olabige O, Nguyen NHK, De Jesus A, Wang YC, Dang A, Hirsch BA, Alonzo TA, Gamis A, Meshinchi S, Lamba JK. Gbadamosi MO, et al. Leukemia. 2022 Aug;36(8):2022-2031. doi: 10.1038/s41375-022-01622-0. Epub 2022 Jun 10. Leukemia. 2022. PMID: 35688939 Free PMC article.

90

Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.

Gadd S, Huff V, Skol AD, Renfro LA, Fernandez CV, Mullen EA, Jones CD, Hoadley KA, Yap KL, Ramirez NC, Aris S, Phung QH, Perlman EJ. Gadd S, et al. Cell Rep Med. 2022 Jun 21;3(6):100644. doi: 10.1016/j.xcrm.2022.100644. Epub 2022 May 25. Cell Rep Med. 2022. PMID: 35617957 Free PMC article.

91

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.

Madanat-Harjuoja LM, Renfro LA, Klega K, Tornwall B, Thorner AR, Nag A, Dix D, Dome JS, Diller LR, Fernandez CV, Mullen EA, Crompton BD. Madanat-Harjuoja LM, et al. J Clin Oncol. 2022 Sep 10;40(26):3047-3056. doi: 10.1200/JCO.22.00098. Epub 2022 May 17. J Clin Oncol. 2022. PMID: 35580298 Free PMC article. Clinical Trial.

92

An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report.

Brown AL, Sok P, Scheurer ME, Rabin KR, Marcotte EL, Hawkins DS, Spector LG, Lupo PJ. Brown AL, et al. Cancer. 2022 Jul 15;128(14):2760-2767. doi: 10.1002/cncr.34248. Epub 2022 Apr 28. Cancer. 2022. PMID: 35482017 Free PMC article.

93

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.

Whittle S, Venkatramani R, Schönstein A, Pack SD, Alaggio R, Vokuhl C, Rudzinski ER, Wulf AL, Zin A, Gruver JR, Arnold MA, Merks JHM, Hettmer S, Koscielniak E, Barr FG, Hawkins DS, Bisogno G, Sparber-Sauer M. Whittle S, et al. Eur J Cancer. 2022 Jun;168:56-64. doi: 10.1016/j.ejca.2022.03.022. Epub 2022 Apr 19. Eur J Cancer. 2022. PMID: 35452896 Free PMC article.

94

JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.

Bodaar K, Yamagata N, Barthe A, Landrigan J, Chonghaile TN, Burns M, Stevenson KE, Devidas M, Loh ML, Hunger SP, Wood B, Silverman LB, Teachey DT, Meijerink JP, Letai A, Gutierrez A. Bodaar K, et al. Leukemia. 2022 Jun;36(6):1499-1507. doi: 10.1038/s41375-022-01558-5. Epub 2022 Apr 11. Leukemia. 2022. PMID: 35411095 Free PMC article.

95

Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).

Chintagumpala MM, Perlman EJ, Tornwall B, Chi YY, Kim Y, Hoffer FA, Kalapurakal JA, Warwick AB, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Fernandez CV, Ritchey ML, Grundy PE, Dome JS, Ehrlich PF. Chintagumpala MM, et al. Cancer. 2022 Jul 1;128(13):2493-2503. doi: 10.1002/cncr.34219. Epub 2022 Apr 5. Cancer. 2022. PMID: 35383900 Free PMC article.

96

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.

Crane JN, Xue W, Qumseya A, Gao Z, Arndt CAS, Donaldson SS, Harrison DJ, Hawkins DS, Linardic CM, Mascarenhas L, Meyer WH, Rodeberg DA, Rudzinski ER, Shulkin BL, Walterhouse DO, Venkatramani R, Weiss AR. Crane JN, et al. Pediatr Blood Cancer. 2022 Jun;69(6):e29644. doi: 10.1002/pbc.29644. Epub 2022 Mar 6. Pediatr Blood Cancer. 2022. PMID: 35253352 Free PMC article. Review.

97

Reply to J.-G. Wang et al.

Leavey PJ, Krailo MD, DuBois SG, Reed DR, Janeway KA, Mascarenhas L. Leavey PJ, et al. J Clin Oncol. 2022 May 1;40(13):1507-1508. doi: 10.1200/JCO.21.02922. Epub 2022 Mar 2. J Clin Oncol. 2022. PMID: 35235382 Free PMC article. No abstract available.

98

Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.

Gupta S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, Winter SS, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Winick NJ, Loh ML, Hunger SP, Devidas M. Gupta S, et al. Cancer. 2022 May 1;128(9):1863-1870. doi: 10.1002/cncr.34150. Epub 2022 Feb 24. Cancer. 2022. PMID: 35201611 Free PMC article.

99

Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.

Guest EM, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz M, Loh ML, Hunger SP, Brown PA. Guest EM, et al. Haematologica. 2022 May 1;107(5):1205-1208. doi: 10.3324/haematol.2021.280146. Haematologica. 2022. PMID: 35172563 Free PMC article. Clinical Trial. No abstract available.

100

Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.

Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts KG, Qian MX, Zhang B, Yang W, Perez-Andreu V, Xu J, Iyyanki S, Kuang D, Stasiak LA, Reshmi SC, Gastier-Foster J, Smith C, Pui CH, Evans WE, Hunger SP, Platanias LC, Relling MV, Mullighan CG, Loh ML, Yue F, Yang JJ. Yang H, et al. Nat Genet. 2022 Feb;54(2):170-179. doi: 10.1038/s41588-021-00993-x. Epub 2022 Feb 3. Nat Genet. 2022. PMID: 35115686 Free PMC article.

101

Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534.

Ehrlich PF, Tornwall B, Chintagumpala MM, Chi YY, Hoffer FA, Perlman EJ, Kalapurakal JA, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Fernandez CV, Dome JS. Ehrlich PF, et al. Ann Surg Oncol. 2022 May;29(5):3252-3261. doi: 10.1245/s10434-021-11266-6. Epub 2022 Jan 24. Ann Surg Oncol. 2022. PMID: 35072864 Free PMC article.

102

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.

Hoff FW, Van Dijk AD, Qiu Y, Hu CW, Ries RE, Ligeralde A, Jenkins GN, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Qutub AA, De Bont ESJM, Horton TM, Kornblau SM. Hoff FW, et al. Haematologica. 2022 Oct 1;107(10):2329-2343. doi: 10.3324/haematol.2021.279672. Haematologica. 2022. PMID: 35021602 Free PMC article.

103

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.

Kahn JM, Pei Q, Friedman DL, Kaplan J, Keller FG, Hodgson D, Wu Y, Appel BE, Bhatia S, Henderson TO, Schwartz CL, Kelly KM, Castellino SM. Kahn JM, et al. Lancet Haematol. 2022 Jan;9(1):e49-e57. doi: 10.1016/S2352-3026(21)00349-5. Lancet Haematol. 2022. PMID: 34971582 Free PMC article. Clinical Trial.

104

Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group.

Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM. Lipshultz ER, et al. Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):536-542. doi: 10.1158/1055-9965.EPI-21-0360. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34810210 Free PMC article.

105

Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.

Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Parikh RR, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):890-900. doi: 10.1016/j.ijrobp.2021.10.152. Epub 2021 Nov 9. Int J Radiat Oncol Biol Phys. 2022. PMID: 34767937 Free PMC article. Clinical Trial.

106

Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.

Katzenstein HM, Malogolowkin MH, Krailo MD, Piao J, Towbin AJ, McCarville MB, Tiao GM, Dunn SP, Langham MR, McGahren ED, Finegold MJ, Ranganathan S, Weldon CB, Thompson PA, Trobaugh-Lotrario AD, O'Neill AF, Furman WL, Chung N, Randazzo J, Rodriguez-Galindo C, Meyers RL. Katzenstein HM, et al. Cancer. 2022 Mar 1;128(5):1057-1065. doi: 10.1002/cncr.34014. Epub 2021 Nov 11. Cancer. 2022. PMID: 34762296 Free PMC article. Clinical Trial.

107

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.

Burke MJ, Devidas M, Chen Z, Salzer WL, Raetz EA, Rabin KR, Heerema NA, Carroll AJ, Gastier-Foster JM, Borowitz MJ, Wood BL, Winick NJ, Carroll WL, Hunger SP, Loh ML, Larsen EC. Burke MJ, et al. Leukemia. 2022 Mar;36(3):648-655. doi: 10.1038/s41375-021-01460-6. Epub 2021 Nov 1. Leukemia. 2022. PMID: 34725453 Free PMC article. Clinical Trial.

108

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.

van Dijk AD, Hoff FW, Qiu Y, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, de Bont ESJM, Kornblau SM, Horton TM. van Dijk AD, et al. Proteomics Clin Appl. 2022 Mar;16(2):e2100072. doi: 10.1002/prca.202100072. Epub 2021 Nov 17. Proteomics Clin Appl. 2022. PMID: 34719869 Free PMC article. Clinical Trial.

109

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.

Johnston RL, Mottok A, Chan FC, Jiang A, Diepstra A, Visser L, Telenius A, Gascoyne RD, Friedman DL, Schwartz CL, Kelly KM, Scott DW, Horton TM, Steidl C. Johnston RL, et al. Blood. 2022 Feb 10;139(6):889-893. doi: 10.1182/blood.2021011941. Blood. 2022. PMID: 34662378 Free PMC article. Clinical Trial.

110

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.

Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, Maciej A, Chuba P, Ahmed AA, Indelicato DJ, Wang D, Marina N, Gorlick R, Janeway KA, Mascarenhas L. Leavey PJ, et al. J Clin Oncol. 2021 Dec 20;39(36):4029-4038. doi: 10.1200/JCO.21.00358. Epub 2021 Oct 15. J Clin Oncol. 2021. PMID: 34652968 Free PMC article. Clinical Trial.

111

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.

Chow EJ, Aplenc R, Vrooman LM, Doody DR, Huang YV, Aggarwal S, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Asselin BL, Schwartz CL, Lipshultz SE. Chow EJ, et al. Cancer. 2022 Feb 15;128(4):788-796. doi: 10.1002/cncr.33974. Epub 2021 Oct 13. Cancer. 2022. PMID: 34644414 Free PMC article. Clinical Trial.

112

Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Russell HV, Chi YY, Okcu MF, Bernhardt MB, Rodriguez-Galindo C, Gupta AA, Hawkins DS. Russell HV, et al. Cancer. 2022 Jan 15;128(2):317-325. doi: 10.1002/cncr.33917. Epub 2021 Oct 8. Cancer. 2022. PMID: 34623638 Free PMC article. Clinical Trial.

113

Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

Dome JS, Mullen EA, Dix DB, Gratias EJ, Ehrlich PF, Daw NC, Geller JI, Chintagumpala M, Khanna G, Kalapurakal JA, Renfro LA, Perlman EJ, Grundy PE, Fernandez CV. Dome JS, et al. J Natl Compr Canc Netw. 2021 Aug 1;19(8):978-985. doi: 10.6004/jnccn.2021.7070. J Natl Compr Canc Netw. 2021. PMID: 34416705 Free PMC article. Review.

114

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, Ramirez NC, Pfau R, Reshmi S, Wagner E, Nuchtern J, Asgharzadeh S, Shimada H, Maris JM, Bagatell R, Park JR, Hogarty MD. Irwin MS, et al. J Clin Oncol. 2021 Oct 10;39(29):3229-3241. doi: 10.1200/JCO.21.00278. Epub 2021 Jul 28. J Clin Oncol. 2021. PMID: 34319759 Free PMC article.

115

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.

Tan KT, Kim H, Carrot-Zhang J, Zhang Y, Kim WJ, Kugener G, Wala JA, Howard TP, Chi YY, Beroukhim R, Li H, Ha G, Alper SL, Perlman EJ, Mullen EA, Hahn WC, Meyerson M, Hong AL. Tan KT, et al. Genome Med. 2021 Jul 14;13(1):114. doi: 10.1186/s13073-021-00929-4. Genome Med. 2021. PMID: 34261517 Free PMC article.

116

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Pinto N, Navarro SL, Rimorin C, Wurscher M, Hawkins DS, McCune JS. Pinto N, et al. Pediatr Blood Cancer. 2021 Nov;68(11):e29203. doi: 10.1002/pbc.29203. Epub 2021 Jul 10. Pediatr Blood Cancer. 2021. PMID: 34245211 Free PMC article.

117

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.

Shern JF, Selfe J, Izquierdo E, Patidar R, Chou HC, Song YK, Yohe ME, Sindiri S, Wei J, Wen X, Rudzinski ER, Barkauskas DA, Lo T, Hall D, Linardic CM, Hughes D, Jamal S, Jenney M, Chisholm J, Brown R, Jones K, Hicks B, Angelini P, George S, Chesler L, Hubank M, Kelsey A, Gatz SA, Skapek SX, Hawkins DS, Shipley JM, Khan J. Shern JF, et al. J Clin Oncol. 2021 Sep 10;39(26):2859-2871. doi: 10.1200/JCO.20.03060. Epub 2021 Jun 24. J Clin Oncol. 2021. PMID: 34166060 Free PMC article.

118

Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1.

Hoppmann AL, Chen Y, Landier W, Hageman L, Evans WE, Wong FL, Relling MV, Bhatia S. Hoppmann AL, et al. Cancer. 2021 Oct 15;127(20):3832-3839. doi: 10.1002/cncr.33760. Epub 2021 Jun 23. Cancer. 2021. PMID: 34161608 Free PMC article.

119

Genome-Wide Approach to Measure Variant-Based Heritability of Drug Outcome Phenotypes.

Muhammad A, Aka IT, Birdwell KA, Gordon AS, Roden DM, Wei WQ, Mosley JD, Van Driest SL. Muhammad A, et al. Clin Pharmacol Ther. 2021 Sep;110(3):714-722. doi: 10.1002/cpt.2323. Epub 2021 Jul 12. Clin Pharmacol Ther. 2021. PMID: 34151428 Free PMC article.

120

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.

Michalski JM, Janss AJ, Vezina LG, Smith KS, Billups CA, Burger PC, Embry LM, Cullen PL, Hardy KK, Pomeroy SL, Bass JK, Perkins SM, Merchant TE, Colte PD, Fitzgerald TJ, Booth TN, Cherlow JM, Muraszko KM, Hadley J, Kumar R, Han Y, Tarbell NJ, Fouladi M, Pollack IF, Packer RJ, Li Y, Gajjar A, Northcott PA. Michalski JM, et al. J Clin Oncol. 2021 Aug 20;39(24):2685-2697. doi: 10.1200/JCO.20.02730. Epub 2021 Jun 10. J Clin Oncol. 2021. PMID: 34110925 Free PMC article. Clinical Trial.

121

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.

Kim J, Light N, Subasri V, Young EL, Wegman-Ostrosky T, Barkauskas DA, Hall D, Lupo PJ, Patidar R, Maese LD, Jones K, Wang M, Tavtigian SV, Wu D, Shlien A, Telfer F, Goldenberg A, Skapek SX, Wei JS, Wen X, Catchpoole D, Hawkins DS, Schiffman JD, Khan J, Malkin D, Stewart DR. Kim J, et al. JCO Precis Oncol. 2021 Jan 11;5:PO.20.00218. doi: 10.1200/PO.20.00218. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34095712 Free PMC article.

122

Validation of healthcare professional proxy-reported children's International Mucositis Evaluation Scale.

Treister NS, Nieder M, Baggott C, Olson E, Lo T, Jin X, Gao Y, Chen L, Dang H, Sung L. Treister NS, et al. Oral Dis. 2023 Mar;29(2):747-754. doi: 10.1111/odi.13918. Epub 2021 May 26. Oral Dis. 2023. PMID: 33993618 Free PMC article.

123

Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.

Rodriguez-Galindo C, Krailo MD, Pinto EM, Pashankar F, Weldon CB, Huang L, Caran EM, Hicks J, McCarville MB, Malkin D, Wasserman JD, de Oliveira Filho AG, LaQuaglia MP, Ward DA, Zambetti G, Mastellaro MJ, Pappo AS, Ribeiro RC. Rodriguez-Galindo C, et al. J Clin Oncol. 2021 Aug 1;39(22):2463-2473. doi: 10.1200/JCO.20.02871. Epub 2021 Apr 6. J Clin Oncol. 2021. PMID: 33822640 Free PMC article. Clinical Trial.

124

Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.

Oshima K, Zhao J, Pérez-Durán P, Brown JA, Patiño-Galindo JA, Chu T, Quinn A, Gunning T, Belver L, Ambesi-Impiombato A, Tosello V, Wang Z, Sulis ML, Kato M, Koh K, Paganin M, Basso G, Balbin M, Nicolas C, Gastier-Foster JM, Devidas M, Loh ML, Paietta E, Tallman MS, Rowe JM, Litzow M, Minden MD, Meijerink J, Rabadan R, Ferrando A. Oshima K, et al. Nat Cancer. 2020 Nov;1(11):1113-1127. doi: 10.1038/s43018-020-00124-1. Epub 2020 Oct 19. Nat Cancer. 2020. PMID: 33796864 Free PMC article.

125

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.

Mattano LA Jr, Devidas M, Maloney KW, Wang C, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick NS, Matloub YH, Marshall DT, Stork LC, Loh ML, Raetz EA, Wood BL, Hunger SP, Carroll WL, Winick NJ. Mattano LA Jr, et al. J Clin Oncol. 2021 May 10;39(14):1540-1552. doi: 10.1200/JCO.20.02370. Epub 2021 Mar 19. J Clin Oncol. 2021. PMID: 33739852 Free PMC article.

126

The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.

Tran TH, Nguyen JV, Stecula A, Akutagawa J, Moorman AV, Braun BS, Sali A, Mullighan CG, Shah NP, Dai Y, Devidas M, Roberts KG, Smith CC, Loh ML. Tran TH, et al. Haematologica. 2021 Aug 1;106(8):2242-2245. doi: 10.3324/haematol.2020.261354. Haematologica. 2021. PMID: 33626861 Free PMC article. No abstract available.

127

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz MJ, Small D, Loh ML, Hunger SP. Brown PA, et al. Leukemia. 2021 May;35(5):1279-1290. doi: 10.1038/s41375-021-01177-6. Epub 2021 Feb 23. Leukemia. 2021. PMID: 33623141 Free PMC article. Clinical Trial.

128

Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.

Rau RE, Dai Y, Devidas M, Rabin KR, Zweidler-McKay P, Angiolillo A, Schore RJ, Burke MJ, Salzer WL, Heerema NA, Carroll AJ, Winick NJ, Hunger SP, Raetz EA, Loh ML, Wood BL, Borowitz MJ. Rau RE, et al. Pediatr Blood Cancer. 2021 Apr;68(4):e28929. doi: 10.1002/pbc.28929. Epub 2021 Feb 9. Pediatr Blood Cancer. 2021. PMID: 33559396 Free PMC article.

129

Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology Group.

Million L, Hayes-Jordan A, Chi YY, Donaldson SS, Wolden S, Morris C, Terezakis S, Laurie F, Morano K, Fitzgerald TJ, Yock TI, Rodeberg DA, Anderson JR, Speights RA, Black JO, Coffin C, McCarville MB, Kao SC, Hawkins DS, Spunt SL, Randall RL. Million L, et al. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):821-830. doi: 10.1016/j.ijrobp.2021.01.051. Epub 2021 Feb 3. Int J Radiat Oncol Biol Phys. 2021. PMID: 33548339 Free PMC article.

130

Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Jacola LM, Baran J, Noll RB, Willard VW, Hardy KK, Embry L, Hullmann SE, Larsen EC, Winick N, Kairalla JA. Jacola LM, et al. Pediatr Blood Cancer. 2021 Apr;68(4):e28913. doi: 10.1002/pbc.28913. Epub 2021 Jan 31. Pediatr Blood Cancer. 2021. PMID: 33522102 Free PMC article. Clinical Trial.

131

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.

Giulino-Roth L, Pei Q, Buxton A, Bush R, Wu Y, Wolden SL, Constine LS, Kelly KM, Schwartz CL, Friedman DL. Giulino-Roth L, et al. Blood. 2021 Mar 18;137(11):1449-1456. doi: 10.1182/blood.2020007225. Blood. 2021. PMID: 33512412 Free PMC article. Clinical Trial.

132

Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.

Aye JM, Xue W, Palmer JD, Walterhouse DO, Arnold MA, Heaton TE, Venkatramani R. Aye JM, et al. Pediatr Blood Cancer. 2021 Apr;68(4):e28914. doi: 10.1002/pbc.28914. Epub 2021 Jan 26. Pediatr Blood Cancer. 2021. PMID: 33501771 Free PMC article. Clinical Trial.

133

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.

Advani AS, Larsen E, Laumann K, Luger SM, Liedtke M, Devidas M, Chen Z, Yin J, Foster MC, Claxton D, Coffan K, Tallman MS, Appelbaum FR, Erba H, Stone RM, Hunger SP, McNeer JL, Loh ML, Raetz E, Winick N, Carroll W, Larson RA, Stock W. Advani AS, et al. Blood Adv. 2021 Jan 26;5(2):504-512. doi: 10.1182/bloodadvances.2020002439. Blood Adv. 2021. PMID: 33496745 Free PMC article.

134

Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932.

Angiolillo AL, Schore RJ, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Lane AR, Maloney KW, Wang C, Bassal M, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Angiolillo AL, et al. J Clin Oncol. 2021 May 1;39(13):1437-1447. doi: 10.1200/JCO.20.00494. Epub 2021 Jan 7. J Clin Oncol. 2021. PMID: 33411585 Free PMC article. Clinical Trial.

135

New approaches to risk stratification for Wilms tumor.

Nelson MV, van den Heuvel-Eibrink MM, Graf N, Dome JS. Nelson MV, et al. Curr Opin Pediatr. 2021 Feb 1;33(1):40-48. doi: 10.1097/MOP.0000000000000988. Epub 2020 Dec 29. Curr Opin Pediatr. 2021. PMID: 33394739 Free PMC article. Review.

136

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.

den Boer ML, Cario G, Moorman AV, Boer JM, de Groot-Kruseman HA, Fiocco M, Escherich G, Imamura T, Yeoh A, Sutton R, Dalla-Pozza L, Kiyokawa N, Schrappe M, Roberts KG, Mullighan CG, Hunger SP, Vora A, Attarbaschi A, Zaliova M, Elitzur S, Cazzaniga G, Biondi A, Loh ML, Pieters R; Ponte di Legno Childhood ALL Working Group. den Boer ML, et al. Lancet Haematol. 2021 Jan;8(1):e55-e66. doi: 10.1016/S2352-3026(20)30353-7. Epub 2020 Dec 22. Lancet Haematol. 2021. PMID: 33357483 Free PMC article. Clinical Trial.

137

How to be successful in an academic interview in pediatric oncology: A survey of Children's Oncology Group (COG) and International Society of Paediatric Oncology (SIOP) mentors.

Bryan G, Morgan JE, Dhall G, Esbenshade AJ. Bryan G, et al. Pediatr Blood Cancer. 2021 Mar;68(3):e28855. doi: 10.1002/pbc.28855. Epub 2020 Dec 23. Pediatr Blood Cancer. 2021. PMID: 33356006 Free PMC article.

138

Metabolic response as assessed by ¹⁸ F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Harrison DJ, Chi YY, Tian J, Hingorani P, Mascarenhas L, McCowage GB, Weigel BJ, Venkatramani R, Wolden SL, Yock TI, Rodeberg DA, Hayes-Jordan AA, Teot LA, Spunt SL, Meyer WH, Hawkins DS, Shulkin BL, Parisi MT. Harrison DJ, et al. Cancer Med. 2021 Feb;10(3):857-866. doi: 10.1002/cam4.3667. Epub 2020 Dec 19. Cancer Med. 2021. PMID: 33340280 Free PMC article.

139

The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.

Shenoy A, Alvarez E, Chi YY, Li M, Shern JF, Khan J, Hiniker SM, Granberg CF, Hawkins DS, Parham DM, Teot LA, Rudzinski ER. Shenoy A, et al. Eur J Cancer. 2021 Jan;143:127-133. doi: 10.1016/j.ejca.2020.10.018. Epub 2020 Dec 7. Eur J Cancer. 2021. PMID: 33302115 Free PMC article.

140

Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.

Chisholm KM, Heerema-McKenney AE, Choi JK, Smith J, Ries RE, Hirsch BA, Raimondi SC, Alonzo TA, Wang YC, Aplenc R, Sung L, Gamis AS, Meshinchi S, Kahwash SB. Chisholm KM, et al. Blood Adv. 2020 Dec 8;4(23):6000-6008. doi: 10.1182/bloodadvances.2020002712. Blood Adv. 2020. PMID: 33284945 Free PMC article.

141

Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.

Gallego S, Chi YY, De Salvo GL, Li M, Merks JHM, Rodeberg DA, van Scheltinga ST, Mascarenhas L, Orbach D, Jenney M, Million L, Minard-Colin V, Wolden S, Zanetti I, Parham DM, Mandeville H, Venkatramani R, Bisogno G, Hawkins DS; European paediatric Soft tissue sarcoma Study Group and Children's Oncology Group. Gallego S, et al. Pediatr Blood Cancer. 2021 Mar;68(3):e28832. doi: 10.1002/pbc.28832. Epub 2020 Nov 27. Pediatr Blood Cancer. 2021. PMID: 33245207 Free PMC article.

142

Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Heske CM, Chi YY, Venkatramani R, Li M, Arnold MA, Dasgupta R, Hiniker SM, Hawkins DS, Mascarenhas L. Heske CM, et al. Cancer. 2021 Mar 15;127(6):946-956. doi: 10.1002/cncr.33334. Epub 2020 Nov 20. Cancer. 2021. PMID: 33216382 Free PMC article.

143

The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia.

Horton TM, Hoff FW, van Dijk A, Jenkins GN, Morrison D, Bhatla T, Hogan L, Romanos-Sirakis E, Meyer J, Carroll WL, Qiu Y, Wang T, Mo Q, Kornblau SM. Horton TM, et al. J Proteomics. 2021 Feb 20;233:104046. doi: 10.1016/j.jprot.2020.104046. Epub 2020 Nov 16. J Proteomics. 2021. PMID: 33212251 Free PMC article.

144

Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report.

Brodersen LE, Gerbing RB, Pardo ML, Alonzo TA, Paine D, Fritschle W, Hsu FC, Pollard JA, Aplenc R, Kahwash SB, Hirsch B, Ramondi S, Wells D, Kolb EA, Gamis AS, Meshinchi S, Loken MR. Brodersen LE, et al. Blood Adv. 2020 Oct 27;4(20):5050-5061. doi: 10.1182/bloodadvances.2020002070. Blood Adv. 2020. PMID: 33080007 Free PMC article.

145

Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.

Lautz TB, Chi YY, Li M, Wolden SL, Casey DL, Routh JC, Granberg CF, Binite O, Rudzinski ER, Hawkins DS, Venkatramani R, Rodeberg DA. Lautz TB, et al. Cancer. 2021 Jan 15;127(2):275-283. doi: 10.1002/cncr.33275. Epub 2020 Oct 20. Cancer. 2021. PMID: 33079399 Free PMC article. Clinical Trial.

146

Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.

Hoff FW, van Dijk AD, Qiu Y, Ruvolo PP, Gerbing RB, Leonti AR, Jenkins GN, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Bruggeman SWM, Kornblau SM, Horton TM. Hoff FW, et al. Blood. 2021 Feb 25;137(8):1050-1060. doi: 10.1182/blood.2020005208. Blood. 2021. PMID: 32959058 Free PMC article. Clinical Trial.

147

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.

Geller JI, Cost NG, Chi YY, Tornwall B, Cajaiba M, Perlman EJ, Kim Y, Mullen EA, Glick RD, Khanna G, Daw NC, Ehrlich P, Fernandez CV, Dome JS; Children's Oncology Group (COG) Renal Tumor Committee. Geller JI, et al. Cancer. 2020 Dec 1;126(23):5156-5164. doi: 10.1002/cncr.33173. Epub 2020 Sep 14. Cancer. 2020. PMID: 32926409 Free PMC article.

148

Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Bhatia S, Hageman L, Chen Y, Wong FL, McQuaid EL, Duncan C, Mascarenhas L, Freyer D, Mba N, Aristizabal P, Walterhouse D, Lew G, Kempert PH, Russell TB, McNall-Knapp RY, Jacobs S, Dang H, Raetz E, Relling MV, Landier W. Bhatia S, et al. JAMA Netw Open. 2020 Aug 3;3(8):e2014205. doi: 10.1001/jamanetworkopen.2020.14205. JAMA Netw Open. 2020. PMID: 32852553 Free PMC article. Clinical Trial.

149

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Dunsmore KP, Winter SS, Devidas M, Wood BL, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi RJ, Gastier-Foster JM, Carroll AJ, Heerema NA, Asselin BL, Rabin KR, Zweidler-Mckay PA, Raetz EA, Loh ML, Schultz KR, Winick NJ, Carroll WL, Hunger SP. Dunsmore KP, et al. J Clin Oncol. 2020 Oct 1;38(28):3282-3293. doi: 10.1200/JCO.20.00256. Epub 2020 Aug 19. J Clin Oncol. 2020. PMID: 32813610 Free PMC article. Clinical Trial.

150

Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.

Nishii R, Baskin-Doerfler R, Yang W, Oak N, Zhao X, Yang W, Hoshitsuki K, Bloom M, Verbist K, Burns M, Li Z, Lin TN, Qian M, Moriyama T, Gastier-Foster JM, Rabin KR, Raetz E, Mullighan C, Pui CH, Yeoh AE, Zhang J, Metzger ML, Klco JM, Hunger SP, Newman S, Wu G, Loh ML, Nichols KE, Yang JJ. Nishii R, et al. Blood. 2021 Jan 21;137(3):364-373. doi: 10.1182/blood.2020006164. Blood. 2021. PMID: 32693409 Free PMC article.

151

Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM. Hayashi RJ, et al. J Clin Oncol. 2020 Sep 10;38(26):3062-3070. doi: 10.1200/JCO.20.00531. Epub 2020 Jun 17. J Clin Oncol. 2020. PMID: 32552472 Free PMC article. Clinical Trial.

152

Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Routh JC, Dasgupta R, Chi YY, Shnorhavorian M, Tian J, Walterhouse DO, Breneman J, Wolden SL, Arndt CA, Hawkins DS, Rodeberg DA. Routh JC, et al. Int J Cancer. 2020 Dec 1;147(11):3168-3176. doi: 10.1002/ijc.33143. Epub 2020 Jul 11. Int J Cancer. 2020. PMID: 32525556 Free PMC article.

153

Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131.

Salzer WL, Burke MJ, Devidas M, Dai Y, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Wood B, Heerema NA, Carroll AJ, Winick N, Carroll WL, Raetz EA, Loh ML, Hunger SP. Salzer WL, et al. J Clin Oncol. 2020 Aug 10;38(23):2628-2638. doi: 10.1200/JCO.19.02892. Epub 2020 Jun 4. J Clin Oncol. 2020. PMID: 32496902 Free PMC article. Clinical Trial.

154

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.

Ehrlich PF, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Tornwall B, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Grundy PE, Fernandez CV, Dome JS. Ehrlich PF, et al. Cancer. 2020 Aug 1;126(15):3516-3525. doi: 10.1002/cncr.32958. Epub 2020 May 27. Cancer. 2020. PMID: 32459384 Free PMC article. Clinical Trial.

155

Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.

Singh P, Wang X, Hageman L, Chen Y, Magdy T, Landier W, Ginsberg JP, Neglia JP, Sklar CA, Castellino SM, Dreyer ZE, Hudson MM, Robison LL, Blanco JG, Relling MV, Burridge P, Bhatia S. Singh P, et al. Cancer. 2020 Sep 1;126(17):4051-4058. doi: 10.1002/cncr.32948. Epub 2020 May 15. Cancer. 2020. PMID: 32413235 Free PMC article.

156

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.

Koneru B, Lopez G, Farooqi A, Conkrite KL, Nguyen TH, Macha SJ, Modi A, Rokita JL, Urias E, Hindle A, Davidson H, Mccoy K, Nance J, Yazdani V, Irwin MS, Yang S, Wheeler DA, Maris JM, Diskin SJ, Reynolds CP. Koneru B, et al. Cancer Res. 2020 Jun 15;80(12):2663-2675. doi: 10.1158/0008-5472.CAN-19-3068. Epub 2020 Apr 14. Cancer Res. 2020. PMID: 32291317 Free PMC article.

157

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Gupta S, Wang C, Raetz EA, Schore R, Salzer WL, Larsen EC, Maloney KW, Mattano LA Jr, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas M. Gupta S, et al. J Clin Oncol. 2020 Jun 10;38(17):1897-1905. doi: 10.1200/JCO.19.03024. Epub 2020 Apr 10. J Clin Oncol. 2020. PMID: 32275469 Free PMC article.

158

Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.

Parsons LN, Mullen EA, Geller JI, Chi YY, Khanna G, Glick RD, Aldrink JH, Vallance KL, Kim Y, Fernandez CV, Dome JS, Perlman EJ. Parsons LN, et al. Cancer. 2020 Jun 15;126(12):2866-2871. doi: 10.1002/cncr.32855. Epub 2020 Apr 8. Cancer. 2020. PMID: 32267967 Free PMC article.

159

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.

Sandberg JK, Chi YY, Smith EA, Servaes S, Hoffer FA, Mullen EA, Perlman EJ, Tornwall B, Ehrlich PF, Geller JI, Grundy PE, Fernandez CV, Dome JS, Khanna G. Sandberg JK, et al. AJR Am J Roentgenol. 2020 May;214(5):987-994. doi: 10.2214/AJR.19.22301. Epub 2020 Mar 11. AJR Am J Roentgenol. 2020. PMID: 32160052 Free PMC article.

160

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.

Daw NC, Chi YY, Kalapurakal JA, Kim Y, Hoffer FA, Geller JI, Perlman EJ, Ehrlich PF, Mullen EA, Warwick AB, Grundy PE, Paulino AC, Gratias E, Ward D, Anderson JR, Khanna G, Tornwall B, Fernandez CV, Dome JS; AREN0321 Study Committee. Daw NC, et al. J Clin Oncol. 2020 May 10;38(14):1558-1568. doi: 10.1200/JCO.19.01265. Epub 2020 Mar 5. J Clin Oncol. 2020. PMID: 32134700 Free PMC article.

161

Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group.

Aye JM, Chi YY, Tian J, Rudzinski ER, Binitie OT, Dasgupta R, Wolden SL, Hawkins DS, Gupta AA. Aye JM, et al. Pediatr Blood Cancer. 2020 May;67(5):e28243. doi: 10.1002/pbc.28243. Epub 2020 Mar 2. Pediatr Blood Cancer. 2020. PMID: 32124549 Free PMC article. Clinical Trial.

162

A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.

Degasperi A, Amarante TD, Czarnecki J, Shooter S, Zou X, Glodzik D, Morganella S, Nanda AS, Badja C, Koh G, Momen SE, Georgakopoulos-Soares I, Dias JML, Young J, Memari Y, Davies H, Nik-Zainal S. Degasperi A, et al. Nat Cancer. 2020 Feb;1(2):249-263. doi: 10.1038/s43018-020-0027-5. Epub 2020 Feb 17. Nat Cancer. 2020. PMID: 32118208 Free PMC article.

163

Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity.

Suiter CC, Moriyama T, Matreyek KA, Yang W, Scaletti ER, Nishii R, Yang W, Hoshitsuki K, Singh M, Trehan A, Parish C, Smith C, Li L, Bhojwani D, Yuen LYP, Li CK, Li CH, Yang YL, Walker GJ, Goodhand JR, Kennedy NA, Klussmann FA, Bhatia S, Relling MV, Kato M, Hori H, Bhatia P, Ahmad T, Yeoh AEJ, Stenmark P, Fowler DM, Yang JJ. Suiter CC, et al. Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5394-5401. doi: 10.1073/pnas.1915680117. Epub 2020 Feb 24. Proc Natl Acad Sci U S A. 2020. PMID: 32094176 Free PMC article.

164

Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group.

Lautz TB, Chi YY, Tian J, Gupta AA, Wolden SL, Routh JC, Casey DL, Dasgupta R, Hawkins DS, Rodeberg DA. Lautz TB, et al. Int J Cancer. 2020 Sep 1;147(5):1419-1426. doi: 10.1002/ijc.32896. Epub 2020 Feb 15. Int J Cancer. 2020. PMID: 32012255 Free PMC article.

165

Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.

Lew G, Chen Y, Lu X, Rheingold SR, Whitlock JA, Devidas M, Hastings CA, Winick NJ, Carroll WL, Wood BL, Borowitz MJ, Pulsipher MA, Hunger SP. Lew G, et al. Haematologica. 2021 Jan 1;106(1):46-55. doi: 10.3324/haematol.2019.237230. Haematologica. 2021. PMID: 32001530 Free PMC article. Clinical Trial.

166

Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.

Maloney KW, Devidas M, Wang C, Mattano LA, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick N, Loh ML, Matloub YH, Marshall DT, Stork LC, Raetz EA, Wood B, Hunger SP, Carroll WL, Winick NJ. Maloney KW, et al. J Clin Oncol. 2020 Feb 20;38(6):602-612. doi: 10.1200/JCO.19.01086. Epub 2019 Dec 11. J Clin Oncol. 2020. PMID: 31825704 Free PMC article. Clinical Trial.

167

A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.

Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, Coffin C, McCarville MB, Randall RL, Parham DM, Black JO, Kao SC, Hayes-Jordan A, Wolden S, Laurie F, Speights R, Kawashima E, Skapek SX, Meyer W, Pappo AS, Hawkins DS. Spunt SL, et al. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2. Epub 2019 Nov 27. Lancet Oncol. 2020. PMID: 31786124 Free PMC article.

168

Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).

Lafay-Cousin L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas A, Billups CA, Fouladi M, Northcott P, Robinson G, Gajjar A. Lafay-Cousin L, et al. J Clin Oncol. 2020 Jan 20;38(3):223-231. doi: 10.1200/JCO.19.00845. Epub 2019 Nov 27. J Clin Oncol. 2020. PMID: 31774708 Free PMC article. Clinical Trial.

169

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.

Vijayakrishnan J, Qian M, Studd JB, Yang W, Kinnersley B, Law PJ, Broderick P, Raetz EA, Allan J, Pui CH, Vora A, Evans WE, Moorman A, Yeoh A, Yang W, Li C, Bartram CR, Mullighan CG, Zimmerman M, Hunger SP, Schrappe M, Relling MV, Stanulla M, Loh ML, Houlston RS, Yang JJ. Vijayakrishnan J, et al. Nat Commun. 2019 Nov 25;10(1):5348. doi: 10.1038/s41467-019-13069-6. Nat Commun. 2019. PMID: 31767839 Free PMC article.

170

Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.

Winick N, Martin PL, Devidas M, Shuster J, Borowitz MJ, Paul Bowman W, Larsen E, Pullen J, Carroll A, Willman C, Hunger SP, Carroll WL, Camitta BM. Winick N, et al. Leukemia. 2020 Apr;34(4):1006-1016. doi: 10.1038/s41375-019-0642-2. Epub 2019 Nov 14. Leukemia. 2020. PMID: 31728054 Free PMC article. Clinical Trial.

171

Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.

Pouliot GP, Degar J, Hinze L, Kochupurakkal B, Vo CD, Burns MA, Moreau L, Ganesa C, Roderick J, Peirs S, Menten B, Loh ML, Hunger SP, Silverman LB, Harris MH, Stevenson KE, Weinstock DM, Weng AP, Van Vlierberghe P, D'Andrea AD, Gutierrez A. Pouliot GP, et al. PLoS One. 2019 Nov 13;14(11):e0221288. doi: 10.1371/journal.pone.0221288. eCollection 2019. PLoS One. 2019. PMID: 31721781 Free PMC article.

172

Replication timing alterations in leukemia affect clinically relevant chromosome domains.

Rivera-Mulia JC, Sasaki T, Trevilla-Garcia C, Nakamichi N, Knapp DJHF, Hammond CA, Chang BH, Tyner JW, Devidas M, Zimmerman J, Klein KN, Somasundaram V, Druker BJ, Gruber TA, Koren A, Eaves CJ, Gilbert DM. Rivera-Mulia JC, et al. Blood Adv. 2019 Nov 12;3(21):3201-3213. doi: 10.1182/bloodadvances.2019000641. Blood Adv. 2019. PMID: 31698451 Free PMC article.

173

Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.

Orgel E, Alexander TB, Wood BL, Kahwash SB, Devidas M, Dai Y, Alonzo TA, Mullighan CG, Inaba H, Hunger SP, Raetz EA, Gamis AS, Rabin KR, Carroll AJ 3rd, Heerema NA, Berman JN, Woods WG, Loh ML, Zweidler-McKay PA, Horan JT; Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Orgel E, et al. Cancer. 2020 Feb 1;126(3):593-601. doi: 10.1002/cncr.32552. Epub 2019 Oct 29. Cancer. 2020. PMID: 31661160 Free PMC article.

174

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS; Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators. Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. doi: 10.1200/JCO.19.00915. Epub 2019 Sep 25. J Clin Oncol. 2019. PMID: 31553693 Free PMC article. Clinical Trial.

175

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.

Rodriguez-Galindo C, Krailo MD, Krasin MJ, Huang L, McCarville MB, Hicks J, Pashankar F, Pappo AS. Rodriguez-Galindo C, et al. J Clin Oncol. 2019 Dec 10;37(35):3369-3376. doi: 10.1200/JCO.19.01276. Epub 2019 Sep 25. J Clin Oncol. 2019. PMID: 31553639 Free PMC article.

176

Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.

Kahn JM, Kelly KM, Pei Q, Bush R, Friedman DL, Keller FG, Bhatia S, Henderson TO, Schwartz CL, Castellino SM. Kahn JM, et al. J Clin Oncol. 2019 Nov 10;37(32):3009-3017. doi: 10.1200/JCO.19.00812. Epub 2019 Sep 20. J Clin Oncol. 2019. PMID: 31539308 Free PMC article.

177

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

Dix DB, Fernandez CV, Chi YY, Mullen EA, Geller JI, Gratias EJ, Khanna G, Kalapurakal JA, Perlman EJ, Seibel NL, Ehrlich PF, Malogolowkin M, Anderson J, Gastier-Foster J, Shamberger RC, Kim Y, Grundy PE, Dome JS; AREN0532 and AREN0533 study committees. Dix DB, et al. J Clin Oncol. 2019 Oct 20;37(30):2769-2777. doi: 10.1200/JCO.18.01972. Epub 2019 Aug 26. J Clin Oncol. 2019. PMID: 31449468 Free PMC article.

178

Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.

Brown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen NA, Peyton SA, Davies GE, Ehli EA, Winick N, Heerema NA, Carroll AJ, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Feingold E, Devidas M, Barcellos LF, Hansen HM, Morimoto L, Kang AY, Smirnov I, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson P, Spector LG, Pombo-de-Oliveira MS, DeWan AT, Mullighan CG, Hunger SP, Pui CH, Loh ML, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang JJ, Lupo PJ, Rabin KR. Brown AL, et al. Blood. 2019 Oct 10;134(15):1227-1237. doi: 10.1182/blood.2018890764. Blood. 2019. PMID: 31350265 Free PMC article.

179

Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.

Daw NC, Chi YY, Kim Y, Mullen EA, Kalapurakal JA, Tian J, Khanna G, Geller JI, Perlman EJ, Ehrlich PF, Warwick AB, Grundy PE, Fernandez CV, Dome JS; AREN0321 Study Committee. Daw NC, et al. Eur J Cancer. 2019 Sep;118:58-66. doi: 10.1016/j.ejca.2019.05.033. Epub 2019 Jul 17. Eur J Cancer. 2019. PMID: 31325873 Free PMC article.

180

Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.

Esbenshade AJ, Kahalley LS, Baertschiger R, Dasgupta R, Goldsmith KC, Nathan PC, Harker-Murray P, Kitko CL, Kolb EA, Murphy ES, Muscal JA, Pierson CR, Reed D, Schore R, Unguru Y, Venkatramani R, Wistinghausen B, Dhall G. Esbenshade AJ, et al. Pediatr Blood Cancer. 2019 Oct;66(10):e27920. doi: 10.1002/pbc.27920. Epub 2019 Jul 16. Pediatr Blood Cancer. 2019. PMID: 31309744 Free PMC article.

181

Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Pardo LM, Voigt AP, Alonzo TA, Wilson ER, Gerbing RB, Paine DJ, Dai F, Menssen AJ, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Wells DA, Brodersen LE, Loken MR. Pardo LM, et al. Cytometry B Clin Cytom. 2020 Jan;98(1):52-56. doi: 10.1002/cyto.b.21829. Epub 2019 Jul 11. Cytometry B Clin Cytom. 2020. PMID: 31294507 Free PMC article.

182

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.

Nagarajan R, Gerbing R, Alonzo T, Johnston DL, Aplenc R, Kolb EA, Meshinchi S, Barakat LP, Sung L. Nagarajan R, et al. Cancer Med. 2019 Aug;8(9):4454-4464. doi: 10.1002/cam4.2337. Epub 2019 Jun 12. Cancer Med. 2019. PMID: 31190442 Free PMC article. Clinical Trial.

183

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.

Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C. Kelly KM, et al. Br J Haematol. 2019 Oct;187(1):39-48. doi: 10.1111/bjh.16014. Epub 2019 Jun 10. Br J Haematol. 2019. PMID: 31180135 Free PMC article. Clinical Trial.

184

Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.

Casey DL, Chi YY, Donaldson SS, Hawkins DS, Tian J, Arndt CA, Rodeberg DA, Routh JC, Lautz TB, Gupta AA, Yock TI, Wolden SL. Casey DL, et al. Cancer. 2019 Sep 15;125(18):3242-3248. doi: 10.1002/cncr.32204. Epub 2019 Jun 7. Cancer. 2019. PMID: 31174239 Free PMC article.

185

Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.

Matloub Y, Rabin KR, Ji L, Devidas M, Hitzler J, Xu X, Bostrom BC, Stork LC, Winick N, Gastier-Foster JM, Heerema NA, Stonerock E, Carroll WL, Hunger SP, Gaynon PS. Matloub Y, et al. Blood Adv. 2019 Jun 11;3(11):1647-1656. doi: 10.1182/bloodadvances.2019032094. Blood Adv. 2019. PMID: 31160295 Free PMC article. Clinical Trial.

186

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee.

Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM. Weldon CB, et al. J Pediatr Surg. 2020 Apr;55(4):655-659. doi: 10.1016/j.jpedsurg.2019.05.004. Epub 2019 May 11. J Pediatr Surg. 2020. PMID: 31126688 Free PMC article.

187

CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Chauhan L, Shin M, Wang YC, Loken M, Pollard J, Aplenc R, Hirsch BA, Raimondi S, Ries RE, Bernstein ID, Gamis AS, Alonzo TA, Meshinchi S, Lamba JK. Chauhan L, et al. JCO Precis Oncol. 2019 May 23;3:PO.18.00387. doi: 10.1200/PO.18.00387. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32914031 Free PMC article.

188

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.

Rafiee R, Chauhan L, Alonzo TA, Wang YC, Elmasry A, Loken MR, Pollard J, Aplenc R, Raimondi S, Hirsch BA, Bernstein ID, Gamis AS, Meshinchi S, Lamba JK. Rafiee R, et al. Blood Cancer J. 2019 May 21;9(6):51. doi: 10.1038/s41408-019-0211-y. Blood Cancer J. 2019. PMID: 31113932 Free PMC article. Clinical Trial.

189

Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.

Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Rodeberg DA, Parham DM, Anderson JR, Meyer WH, Hawkins DS. Mascarenhas L, et al. Cancer. 2019 Aug 1;125(15):2602-2609. doi: 10.1002/cncr.32122. Epub 2019 May 8. Cancer. 2019. PMID: 31067356 Free PMC article.

190

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group.

Raetz EA, Loh ML, Devidas M, Maloney K, Mattano LA Jr, Larsen E, Carroll A, Heerema NA, Gastier-Foster JM, Wood B, Borowitz MJ, Winick N, Hunger SP, Carroll WL. Raetz EA, et al. Haematologica. 2019 Nov;104(11):e517-e520. doi: 10.3324/haematol.2018.215616. Epub 2019 Apr 19. Haematologica. 2019. PMID: 31004024 Free PMC article. No abstract available.

191

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL. Katzenstein HM, et al. Lancet Oncol. 2019 May;20(5):719-727. doi: 10.1016/S1470-2045(18)30895-7. Epub 2019 Apr 8. Lancet Oncol. 2019. PMID: 30975630 Free PMC article. Clinical Trial.

192

Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.

Horton TM, Whitlock JA, Lu X, O'Brien MM, Borowitz MJ, Devidas M, Raetz EA, Brown PA, Carroll WL, Hunger SP. Horton TM, et al. Br J Haematol. 2019 Jul;186(2):274-285. doi: 10.1111/bjh.15919. Epub 2019 Apr 7. Br J Haematol. 2019. PMID: 30957229 Free PMC article. Clinical Trial.

193

Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.

Spunt SL, Francotte N, De Salvo GL, Chi YY, Zanetti I, Hayes-Jordan A, Kao SC, Orbach D, Brennan B, Weiss AR, van Noesel MM, Million L, Alaggio R, Parham DM, Kelsey A, Randall RL, McCarville MB, Bisogno G, Hawkins DS, Ferrari A. Spunt SL, et al. Eur J Cancer. 2019 May;112:98-106. doi: 10.1016/j.ejca.2019.02.001. Epub 2019 Apr 5. Eur J Cancer. 2019. PMID: 30954717 Free PMC article. Clinical Trial.

194

Magnetic resonance and computed tomography imaging features of epithelioid sarcoma in children and young adults with pathological and clinical correlation: a report from Children's Oncology Group study ARST0332.

McCarville MB, Kao SC, Dao TV, Gaffney C, Coffin CM, Parham DM, Hayes-Jordan A, Spunt SL. McCarville MB, et al. Pediatr Radiol. 2019 Jun;49(7):922-932. doi: 10.1007/s00247-019-04389-2. Epub 2019 Mar 30. Pediatr Radiol. 2019. PMID: 30929036 Free PMC article.

195

No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Robinson KM, Yang W, Karol SE, Kornegay N, Jay D, Cheng C, Choi JK, Campana D, Pui CH, Wood B, Borowitz MJ, Gastier-Foster J, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, Devidas M, Mardis ER, Fulton RS, Relling MV, Jeha S. Robinson KM, et al. Pediatr Blood Cancer. 2019 Jun;66(6):e27681. doi: 10.1002/pbc.27681. Epub 2019 Mar 7. Pediatr Blood Cancer. 2019. PMID: 30848065 Free PMC article.

196

Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children's Oncology Group.

Steinherz PG, Seibel NL, Sather H, Ji L, Xu X, Devidas M, Gaynon PS. Steinherz PG, et al. Leukemia. 2019 Sep;33(9):2144-2154. doi: 10.1038/s41375-019-0422-z. Epub 2019 Feb 28. Leukemia. 2019. PMID: 30816331 Free PMC article.

197

Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.

Merchant TE, Bendel AE, Sabin ND, Burger PC, Shaw DW, Chang E, Wu S, Zhou T, Eisenstat DD, Foreman NK, Fuller CE, Anderson ET, Hukin J, Lau CC, Pollack IF, Laningham FH, Lustig RH, Armstrong FD, Handler MH, Williams-Hughes C, Kessel S, Kocak M, Ellison DW, Ramaswamy V. Merchant TE, et al. J Clin Oncol. 2019 Apr 20;37(12):974-983. doi: 10.1200/JCO.18.01765. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811284 Free PMC article. Clinical Trial.

198

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.

Beechinor RJ, Thompson PA, Hwang MF, Vargo RC, Bomgaars LR, Gerhart JG, Dreyer ZE, Gonzalez D. Beechinor RJ, et al. Clin Pharmacokinet. 2019 Jul;58(7):899-910. doi: 10.1007/s40262-018-00734-0. Clin Pharmacokinet. 2019. PMID: 30810947 Free PMC article.

199

Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.

McNeer NA, Philip J, Geiger H, Ries RE, Lavallée VP, Walsh M, Shah M, Arora K, Emde AK, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, Guidry Auvil JM, Meshinchi S, Kentsis A. McNeer NA, et al. Leukemia. 2019 Aug;33(8):1934-1943. doi: 10.1038/s41375-019-0402-3. Epub 2019 Feb 13. Leukemia. 2019. PMID: 30760869 Free PMC article.

200

Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.

McNeer JL, Devidas M, Dai Y, Carroll AJ, Heerema NA, Gastier-Foster JM, Kahwash SB, Borowitz MJ, Wood BL, Larsen E, Maloney KW, Mattano L, Winick NJ, Schultz KR, Hunger SP, Carroll WL, Loh ML, Raetz EA. McNeer JL, et al. J Clin Oncol. 2019 Apr 1;37(10):780-789. doi: 10.1200/JCO.18.00884. Epub 2019 Feb 11. J Clin Oncol. 2019. PMID: 30742559 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

667 results

Results by year